Vapes falsely advertised as nicotine-free sold online without age checks, LBC investigation finds.
We were contacted by LBC to conduct some tests on
ADACT Medical’s Chief Regulatory Officer, Damien Bové, was recently interviewed by respected publication BusinessCann about the European Industrial Hemp Association (EIHA) responding to criticisms over its Novel Food Application studies.
When asked about recent biomedical research actives undertaken by the EIHA, Damien Bové told BusinessCann that ‘this was not an adverse event, but it could lead to adverse events down the line. So it’s an observed event.’
There is a ‘pretty significant margin of error’ for testing in rats in terms of how it relates to human metabolism, and that pharmaceutical studies often test on more than one animal ‘to see if you get the same effect’.
You can read the full interview with BusinessCann at: https://businesscann.com/eiha-responds-to-criticisms-over-its-novel-food-applications-tox-studies/
To discuss Novel Food Applications with ADACT, please call +44(0)1302 986 088 or email [email protected]
We were contacted by LBC to conduct some tests on
With the current crisis that has gripped the vape market
ADACT have been informed of a range of new regulations
A truly big thank you from all of us at
We were contacted by LBC to conduct some tests on a number of
With the current crisis that has gripped the vape market with regard to
ADACT have been informed of a range of new regulations which are are
